Sommaire

Numéro précédent | Numéro suivant

• • ·Does the UK really have an effective cancer plan? Revisited.

    Page :305

    
• • ·Reinventing the wheel?

    Page :305

    
• • ·Accessing unfunded cancer drugs in publicly funded hospitals

    Page :306-307

    Roger Chafe, Irfan A Dhalla, Mark Dobrow, Terrence Sullivan

    
• • ·Screening for ovarian carcinoma: not quite there yet

    Page :308-309

    Ignace Vergote, Frédéric Amant, Lieveke Ameye, Dirk Timmerman

    
• • ·Surrogate endpoints in head and neck cancer

    Page :309-310

    Lucy Chen, Ezra EW Cohen

     
• • ·Assessment of the NHS cancer plan in England

    Page :311

    Mike Richards

     
• • ·Was the NHS cancer plan worth the effort?

    Page :312-313

    Karol Sikora

     
• • ·Live longer but not better … yet

    Page :313-314

    Martin G Sanda

    
• • ·Molecular tests for breast-cancer diagnosis?

    Page :314-315

    Sabine C Linn, Jelle Wesseling

     
• • ·NICE: does guidance set the standard for good health care?

    Page :315-316

    Richard Sainsbury

    
• • ·Erratum

    Page :316

    
• • ·The murky ethics of stem-cell tourism

    Page :317-318

    Norra MacReady

     
• • ·Experts call for urgent skin-cancer awareness campaigns in Chile

    Page :319-320

    Georgina Kenyon

     
• • ·A review of human carcinogens—Part B: biological agents

    Page :321-322

    Véronique Bouvard, Robert Baan, Kurt Straif, Yann Grosse, Béatrice Secretan, Fatiha El Ghissassi, Lamia Benbrahim-Tallaa, Neela Guha, Crystal Freeman, Laurent Galichet, Vincent Cogliano, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group

     
• • ·The Cancer Council Victoria Arts Awards

    Page :323-324

    Adrian Burton

     
• • ·Under the knife

    Page :324-325

    Talha Burki

     
• • ·Reviewing doctors online

    Page :325-326

    Jill Jouret

     
• • ·Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

    Page :327-340

    Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes, Keith Godfrey, David Oram, Jonathan Herod, Karin Williamson, Mourad W Seif, Ian Scott, Tim Mould, Robert Woolas, John Murdoch, Stephen Dobbs, Nazar N Amso, Simon Leeson, Derek Cruickshank, Alistair Mcguire, Stuart Campbell, Lesley Fallowfield, Naveena Singh, Anne Dawnay, Steven J Skates, Mahesh Parmar, Ian Jacobs

    Résumé Résumé Plan Plan  
• • ·Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

    Page :341-350

    Stefan Michiels, Aurélie Le Maître, Marc Buyse, Tomasz Burzykowski, Emilie Maillard, Jan Bogaerts, Jan B Vermorken, Wilfried Budach, Thomas F Pajak, Kian K Ang, Jean Bourhis, Jean-Pierre Pignon, on behalf of the MARCH and MACH-NC Collaborative Groups ‡

    Résumé Résumé Plan Plan   
• • ·Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England

    Page :351-369

    Bernard Rachet, Camille Maringe, Ula Nur, Manuela Quaresma, Anjali Shah, Laura M Woods, Libby Ellis, Sarah Walters, David Forman, John Steward, Michel P Coleman

    Résumé Résumé Plan Plan   
• • ·Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

    Page :370-380

    Per Fransson, Jo-Åsmund Lund, Jan-Erik Damber, Olbjörn Klepp, Fredrik Wiklund, Sophie Fosså, Anders Widmark, for the Scandinavian Prostate Cancer Group Study 7, the Swedish Association for Urological Oncology 3

    Résumé Résumé Plan Plan  
• • ·Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis

    Page :381-390

    Fabrice André, Stefan Michiels, Philippe Dessen, Veronique Scott, Voichita Suciu, Catherine Uzan, Vladimir Lazar, Ludovic Lacroix, Gilles Vassal, Marc Spielmann, Philippe Vielh, Suzette Delaloge

    Résumé Résumé Plan Plan   
• • ·Cardiovascular toxicity caused by cancer treatment: strategies for early detection

    Page :391-399

    Renske Altena, Patrick J Perik, Dirk J van Veldhuisen, Elisabeth GE de Vries, Jourik A Gietema

    Résumé Résumé Plan Plan  
• • ·Management of extracolonic tumours in patients with Lynch syndrome

    Page :400-408

    Jan J Koornstra, Marian JE Mourits, Rolf H Sijmons, Annemarie M Leliveld, Harry Hollema, Jan H Kleibeuker

    Résumé Résumé Plan Plan  
• • ·Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma

    Page :409-416

    B Ashleigh Guadagnolo, Gunar K Zagars

    Résumé Résumé Plan Plan  
• • ·10 years of NICE: still growing and still controversial

    Page :417-424

    Peter Littlejohns, Sarah Garner, Nick Doyle, Fergus Macbeth, David Barnett, Carole Longson

    Résumé Résumé Plan Plan  
• • ·Effect of breast-duct anatomy and wound-healing responses on local tumour recurrence after primary surgery for early breast cancer

    Page :425-429

    Mariella Mannino, John Yarnold

    Résumé Résumé Plan Plan  
• • ·Epstein-Barr virus in Burkitt’s lymphoma: the missing link

    Page :430

    Justin Stebbing, Mark Bower